Posts Tagged ‘ICSI’

The quality of sperm may be more than meets the eye

Friday, May 7th, 2010

For a long time we have been able to assess a man's sperm quality by looking at the number of sperm, the effective motility of the sperm and the shape of the sperm to evaluate a man's fertility potential. But we now know that what we can see only tells us part of the story. In recent years a lot of attention has been paid to the presence or absence of DNA damage in the sperm of men whose partners are not succesful in reproducing even though the female partner's factors predict they should be successful.

An examination of the fragmentation of the DNA in the sperm can be evaluated by a test called Sperm Chromatin Sturcture Assay (SCSA). I have used this test in couples with no other reason for repeated early pregnancy loss and those who have not succeeded with IVF with unexplained poor embryo quality or when I expected success and couple did not achieve it. When we find a high degree of fragmantation the options include life style changes and antioxidant vitamins (about which RPMG's Dr. David Meldrum has written extensively in his Lifestyle & Fertility page on our website) or obtaining immature sperm by testicular biopsy (TESE) before the DNA fragments as the sperm goes through the maturation process. The immature sperm can be used in intracytoplasmic sperm injection (ICSI). In the March 2010 issue of Fertility & Sterility a study confirms that in men with high DNA fragmentation and who have failed antioxidant treatment, ejaculated sperm showed a threefold higher DNA damage when compared with testicular samples (39.7% vs. 13.3%).

I have had a number of couples in which this strategy has worked well. it is something to be considered in IVF failure for no apparent reason or unexpected poor embryo quality or in couples with recurrent pregnancy loss without a documented cause.

All we need from a sperm is its DNA.

Tuesday, March 30th, 2010

And its appearance is not a reflection of the DNA. That's what I've been telling couples when the male has severe abnormalities in his semen parameters. This especially applies to the appearance of the sperm (teratozoospermia), the strict morphology. Now a study in the March 2010 issue of Fertility & Sterility confirms the accuracy of my statement.

They looked at couples going through cycles of IVF with ICSI and correlated their outcomes with the degree of abnormality in the measurement of sperm appearance, the strict morphology. Fertilization rates were high (74%–77%), and clinical pregnancy rates ranged from 60% (subgroup with 0% normal sperm) to 56% (subgroup with ≥7% normal forms). The highest pregnancy and live birth rates were actually observed in eggs fertilized with sperm from specimens with the most severe teratozoospermia. The percentage of high-quality blastocysts was significantly greater in the severely teratozoospermic patients compared with patients with ≥5% normal sperm (37% vs. 28%). This is likely because in the lower morphology subgroups, female factors are less prevalent and the primary infertility problem is male factor.

So, according to this study,  those couples needing IVF with ICSI for severe teratozoospermia can rest assured that they do not have to worry that this abnormaility will adversly affect the outcome of their IVF cycles.